MOREPEN LABORATORIES
Back to Cashflow Statement
|
MOREPEN LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹5.20 Cr | ₹144 Cr | ₹66 Cr | ₹47 Cr | ₹5.49 Cr |
What is the latest Cash Flow from Financing Activities ratio of MOREPEN LABORATORIES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹5.20 Cr |
Mar2023 | ₹144 Cr |
Mar2022 | ₹66 Cr |
Mar2021 | ₹47 Cr |
Mar2020 | ₹5.49 Cr |
How is Cash Flow from Financing Activities of MOREPEN LABORATORIES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹5.20 Cr | -96.37 | |
Mar2023 | ₹144 Cr | 116.39 | |
Mar2022 | ₹66 Cr | 40.32 | |
Mar2021 | ₹47 Cr | 761.39 | |
Mar2020 | ₹5.49 Cr | - |
Compare Cash Flow from Financing Activities of peers of MOREPEN LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MOREPEN LABORATORIES | ₹3,381.7 Cr | -1% | -4.4% | 11.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,584.0 Cr | 0.5% | 0.6% | 9.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹182,147.0 Cr | 3.7% | 5.1% | 49.1% | Stock Analytics | |
CIPLA | ₹120,941.0 Cr | -1% | 1.7% | 2.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹113,325.0 Cr | 3.8% | 6.8% | 22.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,138.0 Cr | -3.7% | 1.9% | -0.3% | Stock Analytics |
MOREPEN LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MOREPEN LABORATORIES | -1% |
-4.4% |
11.3% |
SENSEX | 0.8% |
2.5% |
5.3% |
You may also like the below Video Courses